Label 4229137490 Letrozole 2019 2.5mg
Letrozole Tablet, Film Coated
Product Images NDC 42291-374
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 42291-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Letrozole Tablets 090289 1
Letrozole Tablets 090289 2
In this document, the letrozole and Tamoxifen treatment is compared for 2453 and 2450 patients respectively. The patients treated with letrozole were 20.3% higher than those treated with Tamoxifen. The text also has a table showing the number of patients for each treatment at different intervals (in months). The table has two columns ("letrozole" and "Tamoxifen") and 12 rows indicating the number of patients for each month.*
Letrozole Tablets 090289 3
Letrozole Tablets 090289 4
Letrozole Tablets 090289 5
This text provides information about the time to progression (in days) for two different treatment groups: Letrozole 0.5 mg and Letrozole 2.5 mg. It does not provide additional context or information.*
Letrozole Tablets 090289 6
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
